Journal Mobile Options
Table of Contents
7, No. 6, 2012
Issue release date: December 2012
Section title: Original Article · Originalarbeit
Free Access
Breast Care 2012;7:471–475
(DOI:10.1159/000345462)

Complementary and Alternative Therapies Used by Turkish Breast Cancer Patients Undergoing Chemotherapy

Can G.a · Demir M.b · Aydiner A.c
aIstanbul University, Nursing Faculty, Istanbul, bNamık Kemal University Medical Health School, Tekirdag, cIstanbul University, Institute of Oncology, Istanbul, Turkey

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Abstract

Background: Most breast cancer patients use complementary and alternative medicine (CAM), usually in parallel with their conventional treatments. This study was planned to determine the prevalence and determining factors for use of CAM by breast cancer patients undergoing chemotherapy. Patients and Methods: This descriptive study was carried out between October 2010 and May 2011, and included 96 patients at the Istanbul University Institute of Oncology. The Patient Characteristics form and Complementary and Alternative Medicine Scale were used for data collection. Descriptive and nonparametric tests were performed, and logistic regression analysis was used to predict factors affecting CAM use. Results: Praying was the most frequently used form of CAM, and most of the herbal supplements used by patients were harmless. Herbal use was higher among patients who had local disease (relative risk (RR) 4.48%, 95% confidence interval (CI) 1.12–17.95), and worship was more common among those who had not undergone surgery (RR 4.66%, 95% CI 1.64–13.20). Conclusion: The CAM approaches used by patients were found to be safe. However, sage and flax seed usage for estrogen- and progesterone-positive patients and exercise for patients with spinal metastasis can be inappropriate approaches. It is important to question and inform patients about CAM use during treatment.


  

Author Contacts

Gulbeyaz Can, BSc., MSc., PhD., Assoc. Prof.
Istanbul Universitesi Hemşirelik Fakültesi
Abide-i-Hurriyet cad. 34387 Sisli, Istanbul, Turkey
gulbeyaz@istanbul.edu.tr

  

Article Information

Published online: December 10, 2012
Number of Print Pages : 5

  

Publication Details

Breast Care (Multidisciplinary Journal for Research, Diagnosis and Therapy)

Vol. 7, No. 6, Year 2012 (Cover Date: December 2012)

Journal Editor: Harbeck N. (München), Thomssen C. (Halle/Saale), Gnant M. (Wien)
ISSN: 1661-3791 (Print), eISSN: 1661-3805 (Online)

For additional information: http://www.karger.com/BRC


Article / Publication Details

First-Page Preview
Abstract of Original Article · Originalarbeit

Published online: 12/10/2012
Issue release date: December 2012

Number of Print Pages: 0
Number of Figures: 0
Number of Tables: 0

ISSN: 1661-3791 (Print)
eISSN: 1661-3805 (Online)

For additional information: http://www.karger.com/BRC


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.